Identifying New Therapeutic Targets in Fibrolamellar Hepatocellular Carcinoma |
Stanford University / Julien Sage, PhD |
Innovation Grants |
2018 |
California |
Targeting inhibitory phosphatase signaling in high-risk childhood ALL |
University of California San Francisco / Markus Muschen, MD, PhD |
Innovation Grants |
2011 |
California |
In-vivo characterization of MYCN-driven immunosuppression |
University of California San Francisco / William Weiss, MD/PhD |
Innovation Grants |
2021 |
California |
An Intersection of Cell Metabolism and Differentiation in Childhood Sarcomas |
Cedars-Sinai Medical Center / Sandra Orsulic, PhD |
Innovation Grants |
2013 |
California |
Modeling Pediatric Leukemia in Zebra Fish to Enable Discovery of New Anti- Leukemic Compounds |
University of California, San Diego / David Traver, MD |
Innovation Grants |
2010 |
California |
Targeted Degradation of Proliferative Transcription Factors in Pediatric Cancers |
University of California at Santa Cruz / Seth Rubin, PhD |
Innovation Grants |
2017 |
California |
Predicting Outcome for Patients with Metastatic Neuroblastoma by Analysis of Bone Marrow and Blood for a Neuroblastoma Gene Expression Signature |
Children’s Hospital Los Angeles / Robert Seeger |
Innovation Grants |
2010 |
California |
Saturating CRISPR gene body scans in MLL-rearranged leukemia |
Beckman Research Institute of City of Hope / Chun-Wei Chen, PhD |
Innovation Grants |
2019 |
California |
The role of OCT4 in self-renewal signaling and drug-resistance of childhood acute lymphoblastic leukemia
|
Children’s Hospital Los Angeles / Markus Muschen |
Innovation Grants |
2008 |
California |
High-dimensional Biochemical CyTOF Analysis of Pediatric T cell Leukemias |
University of California San Francisco / Jeroen Roose, PhD |
Innovation Grants |
2015 |
California |